La d-amph6tamine inject6e I. P. s diff6rentes doses s des rats blancs produit des effects qualitativement diff6rents selon les sujets: chez terrains, elle augmente le d6bit de r6ponse, chez d'autres, elle le diminue. Ces differences d& pendent de la dose et du d~bit de r6ponse de contrble. Ces concl
Attenuation by pimozide of the suppressant effect ofd-amphetamine on operant behaviour
โ Scribed by M. J. Morley; C. M. Bradshaw; E. Szabadi
- Publisher
- Springer
- Year
- 1987
- Tongue
- English
- Weight
- 592 KB
- Volume
- 91
- Category
- Article
- ISSN
- 0033-3158
No coin nor oath required. For personal study only.
โฆ Synopsis
The interaction between pimozide (a selective D2-dopamine receptor antagonist) and d-amphetamine on the operant performance of rats maintained under variable-interval schedules of positive reinforcement was examined. In Experiment 1, eight rats responded under variable-interval 30-s and variable-interval 300-s. Pimozide (0.0625, 0.125, 0.25, 0.5 mg/kg) suppressed performance maintained under both schedules in a dose-dependent manner, the degrees of suppression being equivalent in the two schedules. In Experiment 2, 12 rats responded under the same schedules. d-Amphetamine (0.1-3.2 mg/kg) suppressed performance under both schedules, the degree of suppression being somewhat greater in the case of variable-interval 30-s. Pre-treatment with pimozide (0.0625, 0.125 mg/kg) significantly attenuated the suppressant effect of d-amphetamine under both schedules. It is suggested that D2-dopamine receptors may be involved in mediating the suppressant effect of d-amphetamine on operant behaviour.
๐ SIMILAR VOLUMES
Dose-response curves were obtained for the effects of d-amphetamine sulphate (0.1-3.2 mg/kg) on the operant performance of rats in variable-interval 4-min and variableinterval 20-rain schedules of reinforcement. Response rates maintained under variable-interval 4-rain were suppressed in a dose-depen
The purpose of this study was to determine whether repeated treatment (15 days) with d-amphetamine (AMP) or fenfluramine (FEN), administered after a daily 3 h feeding session (e. g. post-session), would result in tolerance or crosstolerance to the decrement in food consumption induced by treatment w